Pathogenesis and treatment of the adult respiratory distress syndrome.

The adult respiratory distress syndrome is an acute clinical illness characterized by noncardiogenic pulmonary edema and refractory hypoxemia. Injury to the alveolar-capillary barrier and lung inflammation lead to intrapulmonary shunting of blood, surfactant depletion, and pulmonary vascular obstruction. Numerous mediators contribute to the pathologic response. Conventional therapy includes treating underlying causes and positive pressure mechanical ventilation. Concern about pressure-induced lung injury had led to new strategies to accomplish adequate gas exchange. Novel therapeutic interventions have included extracorporeal support techniques, use of compounds designed to neutralize proinflammatory cytokines, and administration of surfactants, but these efforts have not definitely affected mortality in randomized trials. Potent antioxidant agents have shown promise in animal models of acute lung injury, but human studies are lacking. Inhaled nitric oxide appears to have temporary effects on pulmonary artery pressure and on ventilation or perfusion relationships, but longer-term efficacy and safety in patients suffering from adult respiratory distress syndrome is unknown and awaits results of ongoing clinical trials.

[1]  R. Moon,et al.  Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry. , 1995, Journal of applied physiology.

[2]  M R Wolfson,et al.  Liquid Ventilation Improves Pulmonary Function, Gas Exchange, and Lung Injury in a Model of Respiratory Failure , 1995, Annals of surgery.

[3]  C. Perret,et al.  Permissive hypercapnia. How permissive should we be? , 1994, American journal of respiratory and critical care medicine.

[4]  C. Piantadosi,et al.  Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. , 1994, Journal of applied physiology.

[5]  Craig R. Smith,et al.  Treatment of Septic Shock with Human Monoclonal Antibody HA-1A , 1994, Annals of Internal Medicine.

[6]  R. Coleman,et al.  Aerosol characteristics of 99mTc-pentetic acid (DTPA) and synthetic surfactant (Exosurf). , 1994, Chest.

[7]  S. Marklund,et al.  Immunocytochemical localization of extracellular superoxide dismutase in human lung. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[8]  R. Moon,et al.  Natural surfactant and hyperoxic lung injury in primates. I. Physiology and biochemistry. , 1994, Journal of applied physiology.

[9]  J. Crapo,et al.  Natural surfactant and hyperoxic lung injury in primates. II. Morphometric analyses. , 1994, Journal of applied physiology.

[10]  Dean F. Sittig,et al.  Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[11]  N. MacIntyre,et al.  Combining pressure‐limiting and volume‐cycling features in a patient‐interactive mechanical breath , 1994, Critical care medicine.

[12]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[13]  Arthur S Slutsky.  Mechanical Ventilation , 1993, Chest.

[14]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Marini Jj.  New options for the ventilatory management of acute lung injury. , 1993 .

[16]  E. Pacht,et al.  Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[17]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[18]  S. Adnot,et al.  Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. , 1993, The American review of respiratory disease.

[19]  C. Piantadosi,et al.  Cold-induced brain edema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. , 1993, The Journal of biological chemistry.

[20]  Gerald D. Murphy,et al.  Inhaled Nitric Oxide: Selective Pulmonary Vasodilation in Cardiac Surgical Patients , 1993 .

[21]  F. Morin,et al.  Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. , 1993, The Journal of pediatrics.

[22]  R. Gibson,et al.  Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. , 1993, The American review of respiratory disease.

[23]  P. Pelosi,et al.  Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. , 1993, JAMA.

[24]  C. Dinarello,et al.  Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. , 1993, JAMA.

[25]  E. Weitzberg,et al.  Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. , 1993, European journal of pharmacology.

[26]  R. Rossaint,et al.  Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. , 1993, Journal of applied physiology.

[27]  S. Marklund,et al.  Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase. , 1993, The Biochemical journal.

[28]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[29]  J. Wain,et al.  Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. , 1993, Circulation research.

[30]  A. Hance,et al.  Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. , 1993, Chest.

[31]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide in Congenital Heart Disease , 1993, Circulation.

[32]  D. Wessel,et al.  Inhaled nitric oxide in chronic obstructive lung disease , 1993, The Lancet.

[33]  F. Taylor,et al.  Three Clinical Presentations of E. coli Sepsis as Studied in the Baboon Model , 1993 .

[34]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[35]  Y. Henry,et al.  Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. , 1992, The Journal of biological chemistry.

[36]  J. Lehot,et al.  Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. , 1992, Anesthesiology.

[37]  E. Shaffer,et al.  Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[38]  Jesse D. Roberts,et al.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[39]  H. Wiedemann,et al.  Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. , 1992, American journal of respiratory cell and molecular biology.

[40]  W. Shoemaker,et al.  Relationship of oxygen consumption and oxygen delivery in surgical patients with ARDS. , 1992, Chest.

[41]  J. Stamler,et al.  Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Buurman,et al.  A role for ELAM-1 in the pathogenesis of MOF during septic shock. , 1992, The Journal of surgical research.

[43]  A. R. Elliott,et al.  High lung volume increases stress failure in pulmonary capillaries. , 1992, Journal of applied physiology.

[44]  S. Moncada.  The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. , 1992, Acta physiologica Scandinavica.

[45]  E. Rackow,et al.  Elevation of cardiac output and oxygen delivery improves outcome in septic shock. , 1992, Chest.

[46]  J. Cohen,et al.  Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Natanson,et al.  Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. , 1992, The American review of respiratory disease.

[48]  D. Schuster,et al.  Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. , 1992, The American review of respiratory disease.

[49]  J. Cummings,et al.  A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. , 1992, The American review of respiratory disease.

[50]  D. Remick,et al.  Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. , 1992, The Journal of clinical investigation.

[51]  T. Clemmer,et al.  The adult respiratory distress syndrome. A report of survival and modifying factors. , 1992, Chest.

[52]  S. Idell,et al.  Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. , 1992, The American review of respiratory disease.

[53]  S. Fujii,et al.  Biosynthesis of blood group I and i antigens in rat tissues. Identification of a novel beta 1-6-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.

[54]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Vallance,et al.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.

[56]  C. Smith,et al.  Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. , 1991, The American journal of physiology.

[57]  E. Bergofsky,et al.  Airway insufflation. Increasing flow rates progressively reduce dead space in respiratory failure. , 1991, The American review of respiratory disease.

[58]  T. Higenbottam,et al.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.

[59]  A. P. Timerman,et al.  Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. , 1991, Chest.

[60]  E. Ellis,et al.  Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury. , 1991, Journal of neurosurgery.

[61]  D. Schuster,et al.  Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? , 1991, Chest.

[62]  R. Wunderink,et al.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. , 1991, Chest.

[63]  C. Smith,et al.  Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. , 1991, The Journal of clinical investigation.

[64]  G. Bernard,et al.  N-acetylcysteine in experimental and clinical acute lung injury. , 1991, The American journal of medicine.

[65]  Jerome J. Schentag,et al.  A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis , 1991 .

[66]  G. Bernard,et al.  Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. , 1991, The American review of respiratory disease.

[67]  J. Gilhooly,et al.  Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. , 1991, Pediatrics.

[68]  R. E. Hoekstra,et al.  Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. , 1991, Pediatrics.

[69]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[70]  D. Gommers,et al.  Intratracheal Surfactant Administration Restores Gas Exchange in Experimental Adult Respiratory Distress Syndrome Associated With Viral Pneumonia , 1991, Anesthesia and analgesia.

[71]  J. Norton,et al.  A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice , 1991, The Journal of experimental medicine.

[72]  C. Dinarello,et al.  A specific receptor antagonist for interleukin 1 prevents Escherichia coli‐induced shock in rabbits , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  C. Sprung,et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. , 1991 .

[74]  G. Machiedo,et al.  Effect of oxygen-free radical scavengers on survival in sepsis. , 1991, The American surgeon.

[75]  P. T. Phang,et al.  Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. , 1991, The American review of respiratory disease.

[76]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock , 1990, Nature.

[77]  E. Abraham,et al.  clinical investigations in critical care-Cardiorespiratory Effects of Pressure Controlled Ventilation in Severe Respiratory Failure * , 2006 .

[78]  T. Kolobow,et al.  Acute lung injury from mechanical ventilation at moderately high airway pressures. , 1990, Journal of applied physiology.

[79]  J. Sznajder,et al.  Adverse Effects of Large Tidal Volume and Low PEEP in Canine Acid Aspiration , 1990 .

[80]  J. Marini.  Strategies to minimize breathing effort during mechanical ventilation. , 1990, Critical care clinics.

[81]  J. Schellekens,et al.  Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock , 1990 .

[82]  W. Dougall,et al.  Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. , 1990, The Journal of biological chemistry.

[83]  S. Marklund,et al.  Extracellular-superoxide dismutase, distribution in the body and therapeutic applications. , 1990, Advances in experimental medicine and biology.

[84]  R. Hooper,et al.  Established ARDS treated with a sustained course of adrenocortical steroids. , 1990, Chest.

[85]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[86]  W. Seeger,et al.  Surfactant abnormalities in patients with respiratory failure after multiple trauma. , 1989, The American review of respiratory disease.

[87]  A. Anzueto,et al.  O2- and pneumonia-induced lung injury. II. Properties of pulmonary surfactant. , 1989, Journal of applied physiology.

[88]  R. Bone,et al.  Clinical Investigations in Critical CareRandomized Double-Blind, Multicenter Study of Prostaglandin E1 in Patients with the Adult Respiratory Distress Syndrome , 1989 .

[89]  W. Buurman,et al.  Plasma tumor necrosis factor and mortality in critically ill septic patients. , 1989, Critical care medicine.

[90]  G. Bernard,et al.  The role of airflow resistance in patients with the adult respiratory distress syndrome. , 1989, The American review of respiratory disease.

[91]  S. Matalon,et al.  Alveolar hyperoxic injury in rabbits receiving exogenous surfactant. , 1989, Journal of applied physiology.

[92]  B. Halliwell.  Protection against oxidants in biological systems : the superoxide theory of oxygen toxicity , 1989 .

[93]  W. Shoemaker,et al.  Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.

[94]  A. Torresin,et al.  Relationships Between Lung Computed Tomographic Density, Gas Exchange, and PEEP in Acute Respiratory Failure , 1988, Anesthesiology.

[95]  A. Fowler,et al.  Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. , 1988, The American review of respiratory disease.

[96]  J. Snapper,et al.  Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep. , 1988, Journal of applied physiology.

[97]  J. Shenep,et al.  Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice. , 1988, Critical care medicine.

[98]  M. Guiguet,et al.  Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. , 1988, The American review of respiratory disease.

[99]  J. Murray,et al.  Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. , 1988, The American review of respiratory disease.

[100]  R. Ulevitch,et al.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.

[101]  G. Vercellotti,et al.  Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. , 1988, Blood.

[102]  M. Cybulsky,et al.  Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[103]  C. Sprung,et al.  High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.

[104]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[105]  A. Waage.  Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. , 1987, Clinical immunology and immunopathology.

[106]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.

[107]  L. Touqui,et al.  Perspectives in platelet-activating factor research. , 1987, Pharmacological reviews.

[108]  W. Henderson,et al.  Eicosanoids and lung inflammation. , 1987, The American review of respiratory disease.

[109]  Abel Fl,et al.  Effect of ibuprofen on the course of canine endotoxin shock. , 1987 .

[110]  F. Kunimoto,et al.  Inhibition of lipid peroxidation improves survival rate of endotoxemic rats. , 1987, Circulatory shock.

[111]  N. MacIntyre,et al.  Jet ventilation at 100 breaths per minute in adult respiratory failure. , 1987, American Review of Respiratory Disease.

[112]  R. Fumagalli,et al.  Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. , 1986, JAMA.

[113]  B. Meyrick.  Pathology of the adult respiratory distress syndrome. , 1986, Critical care clinics.

[114]  B. Warner,et al.  Effect of allopurinol and superoxide dismutase on survival rate in rats with sepsis. , 1986, Current surgery.

[115]  W. Johanson,et al.  Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. , 1986, The American review of respiratory disease.

[116]  N. MacIntyre,et al.  Respiratory function during pressure support ventilation. , 1986, Chest.

[117]  B. Furman,et al.  Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats. , 1986, Circulatory shock.

[118]  N. Voelkel,et al.  Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. , 2015, The American review of respiratory disease.

[119]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[120]  L. Bunegin,et al.  Continuous Flow Apneic Ventilation , 1984, Acta anaesthesiologica Scandinavica.

[121]  S. Matalon,et al.  Interstitial fluid volumes and albumin spaces in pulmonary oxygen toxicity. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[122]  J. Hansen,et al.  Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. , 1984, The Journal of biological chemistry.

[123]  S. Marklund.  Extracellular superoxide dismutase in human tissues and human cell lines. , 1984, The Journal of clinical investigation.

[124]  S. Marklund.  Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. , 1984, The Biochemical journal.

[125]  G. Bernard,et al.  Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. , 1984, The Journal of clinical investigation.

[126]  J. Repine,et al.  Neutrophils and Adult Respiratory Distress Syndrome , 1983, The Lancet.

[127]  J. Crapo,et al.  Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. , 1984, The Journal of clinical investigation.

[128]  J. Snapper,et al.  Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. , 1983, The Journal of clinical investigation.

[129]  J. Snapper,et al.  Effect of endotoxin on airway responsiveness to aerosol histamine in sheep. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[130]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[131]  R. Spragg,et al.  Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. , 1983, The Journal of clinical investigation.

[132]  S. Marklund,et al.  Human copper-containing superoxide dismutase of high molecular weight. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[133]  J. Crapo,et al.  Biology of disease: free radicals and tissue injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[134]  P. Pepe,et al.  Clinical predictors of the adult respiratory distress syndrome. , 1982, American journal of surgery.

[135]  G. Larsen,et al.  PULMONARY MICROVASCULAR ALTERATIONS AND INJURY INDUCED BY COMPLEMENT FRAGMENTS: SYNERGISTIC EFFECT OF COMPLEMENT ACTIVATION, NEUTROPHIL SEQUESTRATION, AND PROSTAGLANDINS * , 1982, Annals of the New York Academy of Sciences.

[136]  P. Ward,et al.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. , 1982, The Journal of clinical investigation.

[137]  J. August,et al.  Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro. , 1981, The Journal of clinical investigation.

[138]  A. Pesenti,et al.  Adult Respiratory Distress Syndrome (Ards): Why Did Ecmo Fail? , 1981, The International journal of artificial organs.

[139]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[140]  M. Doyle,et al.  Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. , 1981, Journal of inorganic biochemistry.

[141]  J. Fletcher,et al.  Indomethacin improves survival after endotoxin in baboons. , 1980, Advances in prostaglandin and thromboxane research.

[142]  J. Crapo,et al.  Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. , 1979, The American journal of pathology.

[143]  E. Weibel,et al.  Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. , 2015, The American review of respiratory disease.

[144]  J. Fletcher,et al.  MODIFICATION, BY ASPIRIN AND INDOMETHACIN, OF THE HAEMODYNAMIC AND PROSTAGLANDIN RELEASING EFFECTS OF E. coli ENDOTOXIN IN THE DOG , 1977, British journal of pharmacology.

[145]  J. Crapo,et al.  The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. , 1977, The American review of respiratory disease.

[146]  R S Kronenberg,et al.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. , 1977, The New England journal of medicine.

[147]  W. Zapol,et al.  Pulmonary hypertension in severe acute respiratory failure. , 1977, The New England journal of medicine.

[148]  W. Zapol,et al.  Vascular obstruction causes pulmonary hypertension in severe acute respiratory failure. , 1977, Chest.

[149]  M. Lamy,et al.  Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. , 1976, The American review of respiratory disease.

[150]  J. Parratt,et al.  E. coli ENDOTOXIN SHOCK IN THE CAT; TREATMENT WITH INDOMETHACIN , 1975, British journal of pharmacology.

[151]  T. Petty,et al.  Positive end-expiratory pressure. Physiology, indications, and contraindications. , 1973, The Journal of thoracic and cardiovascular surgery.

[152]  N. Ratliff,et al.  The lung in hemorrhagic shock. IV. The role of neutrophilic polymorphonuclear leukocytes. , 1971, The American journal of pathology.

[153]  T. Petty,et al.  The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. , 1971, Chest.

[154]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.

[155]  C. Cochrane,et al.  POLYMORPHONUCLEAR LEUKOCYTES IN IMMUNOLOGIC REACTIONS : THE DESTRUCTION OF VASCULAR BASEMENT MEMBRANE IN VIVO AND IN VITRO , 1966 .